KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Change in Inventory: 2016-2024

Historic Change in Inventory for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Dec 2024 value amounting to $130.5 million.

  • Amneal Pharmaceuticals' Change in Inventory fell 28.52% to $30.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.8 million, marking a year-over-year increase of 16.92%. This contributed to the annual value of $130.5 million for FY2024, which is 3.45% up from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Change in Inventory stood at $130.5 million for FY2024, which was up 3.45% from $126.2 million recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' Change in Inventory ranged from a high of $130.5 million in FY2024 and a low of $49.0 million during FY2021.
  • Moreover, its 3-year median value for Change in Inventory was $126.2 million (2023), whereas its average is $119.7 million.
  • Per our database at Business Quant, Amneal Pharmaceuticals' Change in Inventory surged by 457.95% in 2020 and then tumbled by 56.92% in 2021.
  • Amneal Pharmaceuticals' Change in Inventory (Yearly) stood at $113.8 million in 2020, then slumped by 56.92% to $49.0 million in 2021, then soared by 108.91% to $102.4 million in 2022, then rose by 23.23% to $126.2 million in 2023, then rose by 3.45% to $130.5 million in 2024.